Healthcare -
Biotechnology - NASDAQ - US
$ 8.16
-8.36 %
$ 310 M
Market Cap
4.96
P/E
TRDA - COMMON STOCK
Common Stock TRDA - Entrada Therapeutics, Inc.
4 K
LAST VALUE
15.47%
2 YEAR CAGR
31.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR